Bionik Laboratories Corp (BNKL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 292 | 258 | 923 | 158 | 282 |
| Cost of Goods | 70 | 63 | 331 | 144 | 83 |
| Gross Profit | 222 | 195 | 593 | 14 | 199 |
| Operating Expenses | 1,836 | 2,216 | 3,583 | 3,287 | 3,489 |
| Operating Income | -1,543 | -1,959 | -2,660 | -3,129 | -3,207 |
| Interest Expense | 111 | 75 | 179 | 3 | 0 |
| Other Income | 27 | 26 | -13,704 | 161 | -176 |
| Pre-tax Income | -1,628 | -2,007 | -16,543 | -2,970 | -3,383 |
| Net Income Continuous | -1,628 | -2,007 | -16,543 | -2,970 | -3,383 |
| Net Income | $-1,628 | $-2,007 | $-16,543 | $-2,970 | $-3,383 |
| EPS Basic Total Ops | -0.32 | -0.39 | -3.61 | -0.58 | -0.87 |
| EPS Basic Continuous Ops | -0.32 | -0.39 | -3.61 | -0.58 | -0.87 |
| EPS Diluted Total Ops | -0.32 | -0.39 | -3.61 | -0.58 | -0.87 |
| EPS Diluted Continuous Ops | -0.32 | -0.39 | -3.61 | -0.58 | -0.87 |
| EBITDA(a) | $-1,504 | $-1,917 | $-2,566 | $-3,032 | $-3,111 |